Victory Capital Management Inc. reduced its stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 38.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 19,162 shares of the company's stock after selling 12,027 shares during the period. Victory Capital Management Inc. owned 0.13% of U.S. Physical Therapy worth $1,387,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of U.S. Physical Therapy during the fourth quarter worth about $39,000. Lazard Asset Management LLC bought a new stake in shares of U.S. Physical Therapy during the fourth quarter worth about $84,000. Fifth Third Bancorp increased its position in shares of U.S. Physical Therapy by 34.6% during the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock worth $75,000 after acquiring an additional 265 shares in the last quarter. Aquatic Capital Management LLC lifted its holdings in shares of U.S. Physical Therapy by 18.0% in the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock valued at $115,000 after purchasing an additional 198 shares in the last quarter. Finally, First Horizon Advisors Inc. boosted its position in shares of U.S. Physical Therapy by 35.0% during the first quarter. First Horizon Advisors Inc. now owns 1,929 shares of the company's stock valued at $140,000 after buying an additional 500 shares during the last quarter.
Insiders Place Their Bets
In related news, Director Nancy Ham sold 400 shares of U.S. Physical Therapy stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the transaction, the director directly owned 2,594 shares in the company, valued at approximately $202,357.94. The trade was a 13.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 2.00% of the company's stock.
Analyst Upgrades and Downgrades
USPH has been the topic of several analyst reports. Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. JMP Securities reaffirmed a "market outperform" rating and set a $113.00 target price on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Finally, Barrington Research reaffirmed an "outperform" rating and set a $98.00 target price on shares of U.S. Physical Therapy in a research report on Tuesday, July 1st. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $109.00.
View Our Latest Research Report on U.S. Physical Therapy
U.S. Physical Therapy Stock Performance
U.S. Physical Therapy stock traded down $2.94 during midday trading on Friday, reaching $70.21. The stock had a trading volume of 151,519 shares, compared to its average volume of 139,522. U.S. Physical Therapy, Inc. has a 12 month low of $62.77 and a 12 month high of $101.19. The firm's 50-day moving average price is $76.27 and its 200 day moving average price is $77.69. The firm has a market capitalization of $1.07 billion, a PE ratio of 32.21, a P/E/G ratio of 3.63 and a beta of 1.44. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.32.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.46 by $0.02. The business had revenue of $183.79 million for the quarter, compared to analysts' expectations of $176.78 million. U.S. Physical Therapy had a return on equity of 7.89% and a net margin of 4.57%. The firm's quarterly revenue was up 18.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.51 EPS. As a group, research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 23rd were paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date was Friday, May 23rd. U.S. Physical Therapy's payout ratio is currently 82.57%.
About U.S. Physical Therapy
(
Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Further Reading

Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.